Company to present on extended applications of ultrasensitive liquid biopsy assays at 2022 ASCO in Chicago CHICAGO–(BUSINESS WIRE)–#asco–Lucence, the precision oncology company pioneering ultrasensitive liquid biopsy tests using circulating tumor DNA (ctDNA) and circulating tumor RNA (ctRNA), will present promising new data on the extension of its amplicon-based next generation sequencing (NGS) assays to new … [Read more…]

Collaboration Will Provide Galleri Test to 10,000 Veterans Across the U.S. Over the Next Three Years; VA Pittsburgh Healthcare System Announced as First of Approximately 10 Participating Sites Collaboration is Part of REFLECTION, a Real-World Observational Study Evaluating Performance of Galleri in Clinical Settings MENLO PARK, Calif.–(BUSINESS WIRE)–GRAIL, LLC, a healthcare company whose mission is … [Read more…]

DALLAS–(BUSINESS WIRE)–Nearly 90% of healthcare facilities used locum tenens physicians and/or advanced practice professionals to fill gaps in their staffs last year, according to a new survey from AMN Healthcare, the nation’s leader in total healthcare talent solutions. The company’s 2022 Survey of Locum Tenens Staffing Trends indicates that 88% of hospitals, medical groups, and … [Read more…]

BOULDER, Colo.–(BUSINESS WIRE)–Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for the treatment of rare muscle disorders, announced today that members of its senior management team will participate in the following upcoming investor conferences: Jefferies Healthcare Conference Presentation: Friday, June 10, 2022, at 10 am ET … [Read more…]

LifeWorks delivers innovative, flexible, effective mental health support through smartphone, tablet or computer CHICAGO–(BUSINESS WIRE)–LifeWorks, a leading provider of digital and in-person mental health and total wellbeing solutions, today announced a new collaboration with Johns Hopkins Medicine HealthCare Solutions. Johns Hopkins will offer the LifeWorks internet-based cognitive behavioral therapy (iCBT) solution as a component of … [Read more…]

WASHINGTON–(BUSINESS WIRE)–At a time when hospitals are under unprecedented logistical and financial strain, a new industry-wide report illuminates the potential for saving money and reducing waste and emissions by extending the life of “single-use” medical devices through reprocessing. The U.S. Food and Drug Administration regulates the commercial reprocessing industry to assure that devices are as … [Read more…]

Positive Results from the Phase 3 PARADIGM Study in Japanese Patients with Colorectal Cancer to be Presented During the Plenary Session at ASCO, in Collaboration with Amgen Overall Survival Data to be Presented during Oral Sessions at both ASCO and EHA from the Phase 3 ECHELON-1 Trial in Patients with Previously Untreated Advanced Hodgkin Lymphoma, … [Read more…]

WASHINGTON–(BUSINESS WIRE)–#AR—Altoida, Inc., a precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality (AR), today announced the appointment of Dr. Antonella Santuccione Chadha as Chief Medical Officer. In this new role, Dr. Chadha will lead all clinical and medical affairs as the company continues to develop, validate, … [Read more…]

All-in-One Solution Enables Provider in Washington State to Streamline Operational Processes and Boost Website Traffic IRVINE, Calif.–(BUSINESS WIRE)–#EHR—Kareo, a leading provider of cloud-based clinical and practice management software solutions for independent healthcare practices and billing companies, and PatientPop, a market leader in practice growth technology, today announced that their client Bellevue Pain and Wellness, PLLC … [Read more…]

Study entitled “Reducing Pre-analytical Sample QC Failure Rates for Cancer Molecular Genetic Assays with SLIMamp® Technology” published in conjunction with the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting NATICK, Mass.–(BUSINESS WIRE)–Pillar Biosciences, the leader in Decision Medicine™, which develops and distributes next-generation sequencing (NGS) tests to localize testing and reduce time to treatment … [Read more…]